Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older

ClinicalTrials.gov ID: NCT02842866

Public ClinicalTrials.gov record NCT02842866. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 10:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults Age 56 Years and Older

Study identification

NCT ID
NCT02842866
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sanofi Pasteur, a Sanofi Company
Industry
Enrollment
907 participants

Conditions and interventions

Interventions

  • Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine Biological
  • Meningococcal Polysaccharide Vaccine, Groups A, C, Y, and W-135 Combined Biological

Biological

Eligibility (public fields only)

Age range
56 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 14, 2016
Primary completion
Feb 12, 2017
Completion
Feb 12, 2017
Last update posted
Apr 4, 2022

2016 – 2017

United States locations

U.S. sites
35
U.S. states
19
U.S. cities
31
Facility City State ZIP Site status
Not listed Chandler Arizona 85224
Not listed Anaheim California 92801
Not listed San Diego California 92103
Not listed Waterbury Connecticut 06708
Not listed Clearwater Florida 33756
Not listed DeLand Florida 32720
Not listed Jacksonville Florida 32205
Not listed Jacksonville Florida 32216
Not listed Ponte Vedra Florida 32081
Not listed Port Orange Florida 32127
Not listed West Palm Beach Florida 33409
Not listed Lenexa Kansas 66219
Not listed Newton Kansas 67114
Not listed Wichita Kansas 67205
Not listed Elkridge Maryland 21075
Not listed Quincy Massachusetts 02169
Not listed Troy Michigan 48098
Not listed St Louis Missouri 63141
Not listed Endwell New York 13760
Not listed Greensboro North Carolina 27408
Not listed Raleigh North Carolina 27612
Not listed Winston-Salem North Carolina 27103
Not listed Fargo North Dakota 58104
Not listed Cincinnati Ohio 45236
Not listed Cincinnati Ohio 45246
Not listed Grants Pass Oregon 97527
Not listed Allentown Pennsylvania 18012
Not listed Uniontown Pennsylvania 15401
Not listed Mt. Pleasant South Carolina 29464
Not listed Mt. Pleasant South Carolina 29646
Not listed Dallas Texas 75231
Not listed Dallas Texas 75234
Not listed South Jordan Utah 84095
Not listed West Jordan Utah 84088
Not listed Charlottesville Virginia 22911

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02842866, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 4, 2022 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02842866 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →